Paul A Laviolette bought $295K of Pulse Biosciences (PLSE)

Executed May 11, disclosed May 12, the same day.

Value, as filed

$295K

15,000 sh × $19.69

Executed

May 11

the trade date, as filed

Disclosed

May 12

0 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

not yet measured

Not yet measured: the 21-session window has not closed, or the prices around it are not on record.

The filer

PL Paul A Laviolette Chief Executive Officer profile →

Paul A Laviolette (Chief Executive Officer) filed 2 Form 4 reports in the trailing twelve months (2 purchases, 0 sales), most often in PLSE. Across 1 priced purchase filing, the average 21-session return was +33.8% from execution and +33.8% from disclosure (delay-adjusted; derived). The largest single filing was $295K of PLSE (15,000 sh × $19.69, as filed), executed May 11.

The name

PLSE PLSE PLSE · 15 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Paul A Laviolette in PLSE

PLSEPURCHASE PULSE BIOSCIENCES, INC. $295K
15,000 sh × $19.69
Exec May 11
Filed May 11 · 6:53 PM ET